India Now Giving ‘Trump Cure’ to Blunt COVID-19

Written by www.timesnownews.com on April 17, 2020. Posted in Current News

Mumbai: Maharashtra government will give Hydroxychloroquine (HCQ) tablets in slums to curb COVID-19 spread as a preventive measure. The suspected coronavirus patients kept in quarantine centres in Dharavi are likely to be the first to receive them.

Maharashtra health minister Rajesh Tope said that HCQS which is used to treat malaria will be used in Dharavi and other high-infection areas.

He further said it has been used in the United States as preventive medicine against COVID-19.

On Tuesday, Dharavi recorded six new coronavirus disease infections, including two deaths, taking the count of active cases in Asia’s largest slum to 55. The densely populated area has reported seven Covid-19-related deaths so far.

The Brihanmumbai Municipal Corporation (BMC) has listed 29 containment zones and six Red Zones, which reported over 15 Covid-19 positive cases, in Dharavi.

According to a report by Hindustan Times, so far, the civic body has quarantined 2,184 Dharavi residents and tested 138 high-risk contacts and 3,450 low-risk contacts of the patients from the slum.

Life-saving cure for COVID-19: US President Trump

India has lifted the partial ban on the export of hydroxychloroquine, the anti-malaria drug used for Covid-19 disease, and has approved the first list of countries that will receive the first batch of the highly-demanded drug touted by US President Trump as a life-saving cure for COVID-19.

The first list of 13 recipient countries includes the USA, Germany, Spain, Bahrain, Brazil, Bhutan, Nepal, Afghanistan, the Maldives, Bangladesh, Seychelles, Mauritius and the Dominican Republic. As per the government reports, around 14 million tablets and 13.5 tonnes of API will be exported to these countries.